Terms: = Germ cell tumor AND SRC, c-SRC, 6714, ENSG00000197122, P12931, ASV, p60-Src, SRC1, c-src AND Prognosis
74 results:
1. FYN as an emerging biological biomarker for prognosis and potential therapeutic target in LGG.
Zhu J; Shi L; Su Y
Neurol Res; 2024 Sep; 46(9):787-795. PubMed ID: 38752708
[TBL] [Abstract] [Full Text] [Related]
2. Early investigation of a novel SI306 theranostic prodrug for glioblastoma treatment.
Vagaggini C; Petroni D; D'Agostino I; Poggialini F; Cavallini C; Cianciusi A; Salis A; D'Antona L; Francesconi V; Manetti F; Damonte G; Musumeci F; Menichetti L; Dreassi E; Carbone A; Schenone S
Drug Dev Res; 2024 Feb; 85(1):e22158. PubMed ID: 38349262
[TBL] [Abstract] [Full Text] [Related]
3. FOXM1 promote the growth and metastasis of uveal melanoma cells by regulating CDK2 expression.
Bai X; Li S; Luo Y
Int Ophthalmol; 2024 Feb; 44(1):55. PubMed ID: 38342795
[TBL] [Abstract] [Full Text] [Related]
4. Network pharmacology-based strategy to investigate the effect and mechanism of α-solanine against glioma.
Wang C; Liu X; Guo S
BMC Complement Med Ther; 2023 Oct; 23(1):371. PubMed ID: 37865727
[TBL] [Abstract] [Full Text] [Related]
5. Identification of CRKL as an oncogenic biomarker for prognosis and immunotherapy in melanoma, and its potential molecular mechanism.
Li Z; Wu X; Chen S; Zhong J; Qiu X; Kpegah JKSK; Shi K; Can L; Zhang X; Yin M; Xie H; Su J; Zhou J
Genomics; 2023 May; 115(3):110634. PubMed ID: 37121446
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic and predictive impact of abnormal signal volume evolution early after chemoradiotherapy in glioblastoma.
Quan G; Wang T; Ren JL; Xue X; Wang W; Wu Y; Li X; Yuan T
J Neurooncol; 2023 Apr; 162(2):385-396. PubMed ID: 36991305
[TBL] [Abstract] [Full Text] [Related]
7. Antitumor mechanism of kangliu pill on gliomas in mice through PI3K-Akt signaling pathway.
Chen F; Cui JJ; Jiang DC; Wang HZ; Zhuang W; Feng YN; Lin XL; Xi SY
J Ethnopharmacol; 2023 May; 307():116252. PubMed ID: 36775078
[TBL] [Abstract] [Full Text] [Related]
8. Effect of glioma-derived immunoglobulin on biological function of glioma cells.
Lv J; Chen S; Chen X; Xie J; He Z; Fan T; Ma K; Abudurousuli K; Yang J; Qiu X; Dai H
Eur J Cancer; 2022 Nov; 175():86-98. PubMed ID: 36096041
[TBL] [Abstract] [Full Text] [Related]
9. Estrogen receptor variant ER-α36 facilitates estrogen signaling via EGFR in glioblastoma.
Qu C; Wang C; Li H; Li Y; Han C; Tao X; Guan X; Zhang Y; Chen M; Liu J; Zou W
Cell Biol Int; 2022 Nov; 46(11):1759-1774. PubMed ID: 35930599
[TBL] [Abstract] [Full Text] [Related]
10. Propofol enhances stem-like properties of glioma via GABA
Fan X; Gong M; Yu H; Yang H; Wang S; Wang R
Stem Cell Res Ther; 2022 Aug; 13(1):398. PubMed ID: 35927718
[TBL] [Abstract] [Full Text] [Related]
11. TGFBI secreted by tumor-associated macrophages promotes glioblastoma stem cell-driven tumor growth via integrin αvβ5-src-Stat3 signaling.
Peng P; Zhu H; Liu D; Chen Z; Zhang X; Guo Z; Dong M; Wan L; Zhang P; Liu G; Zhang S; Dong F; Hu F; Cheng F; Huang S; Guo D; Zhang B; Yu X; Wan F
Theranostics; 2022; 12(9):4221-4236. PubMed ID: 35673564
[No Abstract] [Full Text] [Related]
12. Integrative molecular and clinical profiling of acral melanoma links focal amplification of 22q11.21 to metastasis.
Farshidfar F; Rhrissorrakrai K; Levovitz C; Peng C; Knight J; Bacchiocchi A; Su J; Yin M; Sznol M; Ariyan S; Clune J; Olino K; Parida L; Nikolaus J; Zhang M; Zhao S; Wang Y; Huang G; Wan M; Li X; Cao J; Yan Q; Chen X; Newman AM; Halaban R
Nat Commun; 2022 Feb; 13(1):898. PubMed ID: 35197475
[TBL] [Abstract] [Full Text] [Related]
13. YAP1-mediated regulation of mitochondrial dynamics in IDH1 mutant gliomas.
Patrick S; Gowda P; Lathoria K; Suri V; Sen E
J Cell Sci; 2021 Nov; 134(22):. PubMed ID: 34651186
[TBL] [Abstract] [Full Text] [Related]
14. PPFIBP1 induces glioma cell migration and invasion through FAK/src/JNK signaling pathway.
Dong C; Li X; Yang J; Yuan D; Zhou Y; Zhang Y; Shi G; Zhang R; Liu J; Fu P; Sun M
Cell Death Dis; 2021 Sep; 12(9):827. PubMed ID: 34480020
[TBL] [Abstract] [Full Text] [Related]
15. A novel patient stratification strategy to enhance the therapeutic efficacy of dasatinib in glioblastoma.
Alhalabi OT; Fletcher MNC; Hielscher T; Kessler T; Lokumcu T; Baumgartner U; Wittmann E; Schlue S; Göttmann M; Rahman S; Hai L; Hansen-Palmus L; Puccio L; Nakano I; Herold-Mende C; Day BW; Wick W; Sahm F; Phillips E; Goidts V
Neuro Oncol; 2022 Jan; 24(1):39-51. PubMed ID: 34232320
[TBL] [Abstract] [Full Text] [Related]
16. GBP5 drives malignancy of glioblastoma via the src/ERK1/2/MMP3 pathway.
Yu X; Jin J; Zheng Y; Zhu H; Xu H; Ma J; Lan Q; Zhuang Z; Chen CC; Li M
Cell Death Dis; 2021 Feb; 12(2):203. PubMed ID: 33608513
[TBL] [Abstract] [Full Text] [Related]
17. EGFR/src/ERK-stabilized YTHDF2 promotes cholesterol dysregulation and invasive growth of glioblastoma.
Fang R; Chen X; Zhang S; Shi H; Ye Y; Shi H; Zou Z; Li P; Guo Q; Ma L; He C; Huang S
Nat Commun; 2021 Jan; 12(1):177. PubMed ID: 33420027
[TBL] [Abstract] [Full Text] [Related]
18. Drug repurposing using transcriptome sequencing and virtual drug screening in a patient with glioblastoma.
Saeed MEM; Kadioglu O; Greten HJ; Yildirim A; Mayr K; Wenz F; Giordano FA; Efferth T
Invest New Drugs; 2021 Jun; 39(3):670-685. PubMed ID: 33313992
[TBL] [Abstract] [Full Text] [Related]
19. Targeting metabolic plasticity in glioma stem cells in vitro and in vivo through specific inhibition of c-src by TAT-Cx43
Pelaz SG; Jaraíz-Rodríguez M; Álvarez-Vázquez A; Talaverón R; García-Vicente L; Flores-Hernández R; Gómez de Cedrón M; Tabernero M; Ramírez de Molina A; Lillo C; Medina JM; Tabernero A
EBioMedicine; 2020 Dec; 62():103134. PubMed ID: 33254027
[TBL] [Abstract] [Full Text] [Related]
20. Steroid receptor coactivator-1 enhances the stemness of glioblastoma by activating long noncoding RNA XIST/miR-152/KLF4 pathway.
Gong M; Wang X; Mu L; Wang Y; Pan J; Yuan X; Zhou H; Xing J; Wang R; Sun J; Liu Q; Zhang X; Wang L; Chen Y; Pei Y; Li S; Liu L; Zhao Y; Yuan Y
Cancer Sci; 2021 Feb; 112(2):604-618. PubMed ID: 33090636
[TBL] [Abstract] [Full Text] [Related]
[Next]